Grant Requests
The Leiomyosarcoma Support & Direct Research Foundation's Grant Requests fund innovative basic and translational research to improve LMS diagnostics, prognostics, and therapies.
Funder: Leiomyosarcoma Support & Direct Research Foundation
Due Dates: August 30, 2026: Project abstract submission deadline (annual)
Funding Amounts: Most awards: $50,000–$100,000/year (up to $200,000 total) for 1–2 years; larger grants possible at Board's discretion.
Summary: Annual grants supporting innovative basic and translational research in leiomyosarcoma, focused on diagnostics, prognostics, and novel therapies.
Key Information: Abstract submission is required first; no PI salary, institutional overhead, or travel costs allowed.
Description
The Leiomyosarcoma Support & Direct Research Foundation (LMSDR) offers annual research grants to investigators pursuing impactful studies in leiomyosarcoma (LMS). The program emphasizes both basic science and translational research, with the goal of advancing molecular understanding of uterine and non-uterine LMS, improving diagnostic tools, discovering new prognostic markers, and developing innovative therapies to improve survival and quality of life for patients. Career development for researchers in the field is also a key priority. The grants are intended primarily for promising new research projects, not for work where funding has previously lapsed or was disapproved.
